SAT-LB113 Psychosocial Benefits of Using Basal-IQ® Predictive Low Glucose Suspend Technology in a Real-World Setting: Results From Pediatric Patients With Type 1 Diabetes

Recent literature has highlighted remarkable clinical benefits of the Basal-IQ PredictiveLow Glucose Suspend (PLGS) technology for both pediatric and adult patients with type 1diabetes (PwT1D). Although less frequently acknowledged in the literature, psychosocial benefits and other patient-reported...

Descripción completa

Detalles Bibliográficos
Autores principales: Singh, Harsimran, Manning, Michelle, McElwee-Malloy, Molly, Habif, Steph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Diabetes Mellitus and Glucose Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208362/
http://dx.doi.org/10.1210/jendso/bvaa046.2088

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7208362/
http://dx.doi.org/10.1210/jendso/bvaa046.2088

Ejemplares similares